Aza-pyridone compounds and uses thereof

Methods and reagents for radiolabeling

Pet imaging agents

Deuterated benzimidazole compound and medical use thereof

Pyridone derivatives having tetrahydropyranylmethyl groups

Radiolabeled pharmaceuticals and methods of making and using same

AZETIDINYLOXYPHENYLPYRROLIDINE COMPOUNDS

[18F] fluoride cryptate complexes for radiolabeling fluorinations

Radiotracer derivatives of trimethoprim for diagnostic imaging

BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2

18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS

Dihydroxyphenyl Neurotransmitter Compounds, Compositions And Methods

Organic electroluminescent materials and devices

IN VIVO STABLE HG-197(M) COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF IN NUCLEAR MEDICAL DIAGNOSTICS AND ENDORADIONUCLIDE THERAPY (THERANOSTICS)

Deuterated idebenone

Oxysterols and methods of use thereof

Deuterated compounds, compositions, and methods for treating cancers associated with ETBR activation

Sulphamoylaryl derivatives and use thereof as medicaments for the treatment of liver fibrosis

Hexa-lactoside-triazanonane triacetic acid (NOTA) derivative, method for radiolabeling hexa-lactoside positron emission tomography (PET) imaging agent for liver receptor with Ga-68, and hexa-lactoside PET imaging agent for liver receptor

Creatine prodrugs, compositions and methods of use thereof

Morphinan derivatives and use thereof

Method for preparing hispidulin and its derivatives

Methods for multi-dose synthesis of [F-18]FDDNP for clinical settings

Isotopologues of 2-(tert butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide

Inhibitors of creatine transport and uses thereof

AZA-pyridone compounds and uses thereof

DEUTERATED DERIVATIVES OF RUXOLITINIB

Process for the preparation of hyperpolarized carboxylate compounds

INHIBITORS OF ERK AND METHODS OF USE

ARYL SUBSTITUTED INDOLES AND THE USE THEREOF

Organic electroluminescence device and polycyclic compound for organic electroluminescence device

Cyclic peroxides as prodrugs for selective delivery of agents

Isotopically modified components and therapeutic uses thereof

Methods for the iodination of biomolecules

Aminopyrazine diol compounds as PI3K-γ inhibitors

Method for producing radiopharmaceutical composition

Hyperpolarized 1-13C-1,1-bis(acetoxy(methyl))-2,2′-cyclopropane as metabolic marker for MR

Pharmaceutical compositions comprising POH derivatives

Hyperpolarized [3-C]acetoacetate and methods of using the same

Radiolabeling Agents, Methods of Making, and Methods of Use Thereof

Substituted boric acid compound, pharmaceutical composition comprising same, and application thereof

Glucosylceramide synthase inhibitors for the treatment of diseases

Precursors for radiofluorination

Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods

Compounds useful as inhibitors of ATR kinase

Alpha-synuclein ligands

Half-curcuminoids as amyloid-beta PET imaging agents

COT MODULATORS AND METHODS OF USE THEREOF

Deuterated compounds for treating Fabry, Gaucher, Parkinson's and related diseases and conditions, and compositions and methods thereof

IRAK4 inhibiting agents

F-labeled compounds for PET imaging and uses thereof

Deuterated domperidone compositions, methods, and preparation

Methods for the synthesis of deuterated dextromethorphan

Imaging histone deacetylases with a radiotracer using positron emission tomography

Deuterated 3-(4,5-substituted aminopyrimidine)phenyl derivatives and use thereof

Deuterated Venetoclax

Triazole conjugated ureas, thioureas, carbamates, and reversed carbamates for PSMA-targeted imaging agents and uses thereof

Carbonyl containing compound high-throughput quantitative analysis using isobaric multiplex reagents

RADIOTRACERS FOR IMAGING ER-POSITIVE BREAST CANCER

Deuterated compounds, compositions, and methods for treating cancers associated with ETBR activation

Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the same

Deuterated compounds and uses thereof

Preparation of Pb labeled monoclonal antibodies

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

RADIOFLUORINATED CARBOXIMIDAMIDES AS IDO TARGETING PET TRACER FOR CANCER IMAGING

Lead and thorium compounds

Protein kinase regulators

Biaryl amide compounds as kinase inhibitors

Fluorine- and/or deuterium-containing compounds for treating non-small cell lung cancer and related diseases

2-(3-pyridinyl)-1H-benzimidazole derivative compound and medicament containing same

Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia

Deuterated CFTR potentiators

Methods of treating neurofibromatosis with perillyl alcohol

Alkylation method

Methods of using leuco colorants as bluing agents in laundry care compositions

Compounds, reagents, and uses thereof

Methods for detecting and determining levels of monolignol ester conjugates incorporated into lignin and compounds relating thereto

Amino compounds for treatment of complement mediated disorders

Process for preparing deuterated desmosine and derivatives thereof

DEUTERATED COMPOUNDS AS IMMUNOMODULATORS

Double targeted constructs to affect tumor kill

Process for preparation of tetrabenazine and deutetrabenazine

Methods of Making Deuterium-Enriched N-acetylcysteine Amide (D-NACA) and (2R, 2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress

F-FNDP for pet imaging of soluble epoxide hydrolase (sEH)

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

NEW NUCLEOPHILE-REACTIVE SULFONATED COMPOUNDS FOR THE (RADIO)LABELLING OF (BIO)MOLECULES; PRECURSORS AND CONJUGATES THEREOF

6-(5-membered heteroaryl)isoquinolin-3-yl carboxamides and preparation and use thereof

PET-imaging immunomodulators

IODINATED PHENOLIC LIPIDS AND METHODS AND COSOLVENT SYSTEMS FOR IODINATION OF PHENOLIC LIPIDS

Hydroxamic acid type contrast agent containing radioisotope fluoride, preparation method and application thereof

Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same

Bromotriazole intermediates

4-HYDROXYBUTYRIC ACID ANALOGS

Substituted heteroaryl compound, composition containing same, and application thereof

METHODS OF MANUFACTURING BENZOQUINOLINE COMPOUNDS

Phosphonate compounds for treatment of complement mediated disorders

Hepatitis B antiviral agents

Analogs of fexaramine and methods of making and using

Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents

Site-specific isotopic labeling of 1,4-diene systems

Formulations And Pharmacokinetics Of Deuterated Benzoquinoline Inhibitors Of Vesicular Monoamine Transporter 2

Substituted bicyclic compounds

BICYCLIC COMPOUNDS FOR DIAGNOSIS AND THERAPY

Protein kinase inhibitors

MULTIPLE-FUNCTIONAL PROBE AND USES THEREOF

PROCESSES FOR THE PRODUCTION OF TEREPHTHALATE DERIVATIVES AND COMPOSITIONS THEREOF

Organic electroluminescent materials and devices

Compound for specifically binding to amyloid β-protein

CXCR4 receptor antagonists

Heterocyclic derivatives and their use in the treatment of neurological disorders

DEUTERIUM-SUBSTITUTED QUINOLINE DERIVATIVES

Heterocyclic compound

Hepatitis B antiviral agents

ORGANOTRIFLUOROBORATE MIMICS OF AMINO ACIDS AND USES THEREOF

Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity

Catalytic radiofluorination

Ether compounds for treatment of complement mediated disorders

DEUTERIUM-MODIFIED CFTR MODULATORS

Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases

AZETIDINE MODULATORS OF THE SPHINGOSINE 1-PHOSPHATE RECEPTOR

Deuterated GFT-505

3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof

Radiolabeled monoacylglycerol lipase occupancy probe

Steroidal compound, composition containing the same and use thereof

Tetrahydro-Pyrido-Pyrimidine Derivatives

Substituted dihydroisoquinolinone compounds

Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia

TAU PET IMAGING LIGANDS

Compounds for treatment of complement mediated disorders

Deuterated triazolopyridazine as a kinase modulator

Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

Radiolabeled erlotinib analogs and uses thereof

Method for synthesizing iodo- or astatoarenes using diaryliodonium salts

Tracer Substances for SVC Analysis

Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity

Carboxamides as modulators of sodium channels

Organic compound and organic electroluminescent element comprising same

Deuterated idebenone

Process for producing Gallium-68 through the irradiation of a solution target

18/19F-labelled compounds which target the prostate specific membrane antigen

Positive allosteric modulators of the GLP-1 receptor

Compositions and methods for treating multiple myeloma

Deuterium-enriched pioglitazone

Compositions for binding sphingosine-1-phosphate receptor 1 (S1P1), imaging of S1P1, and methods of use thereof

PURIFICATION METHOD

Isobaric mass labels

Isotopic fluorination and applications thereof

Isobaric mass labels having n',n'-dimeihyl piperazine-2-carboxylic acid reporter moieties

TYK2 inhibitors and uses thereof

Oxaspiro[2.5]octane derivatives and analogs

Deuterated compounds and uses thereof

MONONUCLEOTIDES HAVING A BIOREVERSIBLE DISULFIDE GROUP

Heteroaromatic silicon-fluoride-acceptors useful for F labeling of molecules and biomolecules, and methods of preparing same

Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application

Probes for 18F Positron Emission Tomography Imaging

Site-specific isotopic labeling of 1,4-diene systems

Ligands for imaging cardiac innervation

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors

2',6'-DIOXO-3'-DEUTERO-PIPERDIN-3-YL-ISOINDOLINE COMPOUNDS

COMPOUND AND PHARMACEUTICAL COMPOSITION FOR TARGETED DRUG DELIVERY

Inhibitors of lysine specific demethylase-1

Co-crystals and pharmaceutical compositions comprising the same

Triazole agonists of the APJ receptor

Compositions, methods, and systems for the synthesis and use of imaging agents

KDM1A inhibitors for the treatment of disease

Process for the preparation of deuterated ethanol from D2

Process for the preparation of deuterated ethanol from DO

DEUTERATED COMPOUNDS

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

1, 3, 4-thiadiazole compounds and their use in treating cancer

Substituted triazolobenzodiazepines

Isotopically modified compounds and their use as food supplements

Alkyne Compounds for Treatment of Complement Mediated Disorders

Compound for specifically binding to amyloid β-protein

Deuterated OTX-015

CORTISTATIN ANALOGS AND USES THEREOF

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Tritiated nitroxides and uses thereof

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

Deuterated 3-methanesulfonylpropionitrile

PROTEASOME ACTIVITY ENHANCING COMPOUNDS

Azetidine derivatives for tau imaging

Small Molecule Drug Conjugates

Continudihydroxyphenyl Neurotransmitter Compounds, Compositions And Methods

Lipophenol compounds and uses thereof

PET Imaging agents

Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof

Methods for low temperature fluorine-18 radiolabeling of biomolecules

6,7-cyclicmorphinan derivatives and use thereof

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof

Radiolabelled mGluR2 PET ligands

Organic electroluminescent materials and devices

Imaging agents for neural flux

Bicyclic aza compounds as muscarinic M1 receptor antagonists

Precursor compound of radioactive halogen-labeled organic compound

Substituted Phenethylamines With Serotoninergic And/Or Norepinephrinergic Activity

Methods and reagents for radiolabeling

Compounds for the treatment of hepatitis B virus infection

Amine-based compound and organic light emitting device comprising same

2-AMINO-3-FLUORO-3-(FLUOROMETHYL)-6-METHYL-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINES AS BACE1 INHIBITORS

COT MODULATORS AND METHODS OF USE THEREOF

Inhibitors of ERK and methods of use

PSMA-binding agents and uses thereof

Imaging agents

METHODS OF MANUFACTURING BENZOQUINOLINE COMPOUNDS

Mono-, di- or polysaccharide used as metal inhibitor in the preparation of 68Ga-chelate-functionalized targeting agent

Kit for radiolabelling with 68GA comprising a metal inhibitor

Methylsulfonamide derivatives and uses related thereto

Deuterated baricitinib

Automatic process platform for the production of astatine-211 [At 211] radiopharmaceuticals

Method for urea conversion efficiency measurement

Compounds, compositions, and methods

Chelated PSMA inhibitors

Compound that specifically binds to AMPA receptor

Bridged bicyclic kallikrein inhibitors

18F—tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer

RENAL IMAGING AGENT

Deuterated thienopiperidine derivatives, manufacturing method, and application thereof

Nitration of aromatic compounds

Radiolabelling Process

Pyrimidine-2,4-diamine derivatives for treatment of cancer

Inhibitors of CXCR2

Heterocyclic compound

DEVICE AND METHOD FOR PRODUCING RADIOACTIVELY LABELED COMPOUND

4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof

Compositions and methods for inhibition of the JAK pathway

Modulators of ATP-binding cassette transporters

Silylations of aromatic substrates with base-activated organosilanes

4-hydroxybutyric acid analogs

Deuterated O-sulfated beta lactam hydroxamic acids and deuterated N-sulfated beta lactams

Pyridone derivatives having tetrahydropyranylmethyl groups

Fused pyridines as kinase inhibitors

Indazoles and use thereof

MAGL inhibitors

Tricyclic sulfones as ROR gamma modulators

(2-amino-4-(arylamino)phenyl carbamates

Methods for multi-dose synthesis of [F-18]FDDNP for clinical settings

Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same

5-DEUTERO-THIAZOLIDINYLDIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME

2',6'-DIOXO-3'-DEUTERO-PIPERDIN-3-YL-ISOINDOLINE COMPOUNDS

Heterocyclic morphinan derivatives and use thereof

Radiotracer derivatives of trimethoprim for diagnostic imaging

Protein kinase inhibitors

Protein kinase inhibitors

Cognition Enhancing Compounds and Compositions, Methods of Making, and Methods of Treating

Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

Compound and organic electronic element comprising same

Positive allosteric modulators of the muscarinic acetylcholine receptor M

WDR5 inhibitors and modulators

Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase

Substituted oxopyridine derivatives and use thereof cardiovascular disorders

Deuterated CFTR potentiators

Substituted Phenethylamines With Serotoninergic And/Or Norepinephrinergic Activity

Deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

Spirocyclic compounds as agonists of the muscarinic Mreceptor and/or Mreceptor

Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof

Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrilary tangles

Functionally modified polypeptides and radiobiosynthesis

Inhibitors of growth factor activation enzymes

DEUTERIUM-ENRICHED HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE ENZYME INHIBITORS

Introduction of alkyl substituents to aromatic compounds

Deuterium-Substituted Oxazepin Compounds

Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors

Condensed-cyclic compound and organic light-emitting device including the same

METHOD FOR PREPARING PRECURSOR OF GENE EXPRESSION PROBE

Compounds, compositions, and methods

Compound and organic electronic device using the same

Compound and organic electronic device using the same

Spiro compound and organic electronic device comprising the same

Method for preparing largazole analogs and uses thereof

DEUTERATED EMRICASAN

Imaging tumor glycolysis by non-invasive measurement of pyruvate kinase M2

Heterocyclic Compounds and Uses Thereof

TARGETED, METAL-CATALYZED FLUORINATION OF COMPLEX COMPOUNDS WITH FLUORIDE ION VIA DECARBOXYLATION

Dimethoxyphenyl inhibitors of vesicular monoamine transporter 2

Compound for organic electric element, organic electric element using the same, and electronic device comprising same

Deuterated chenodeoxycholic acid derivative and pharmaceutical composition comprising compound thereof

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

PHOSPHONIUM COMPOUND AND PRODUCTION METHOD THEREFOR

Synthesis of a radioactive agent composition

Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition

Metal complexes

Compound for organic electric element, organic electric element using the same, and electronic device comprising same

Compounds for treatment of complement mediated disorders

Ether compounds for treatment of complement mediated disorders

N-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6- dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (SGC) for the treatment of cardiovascular diseases

9H-PYRROLO-DIPYRIDINE DERIVATIVES

Carboxylic acid compound, method for preparation thereof, and use thereof

Compounds for the treatment of hepatitis C

ISOTOPOLOGUES OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE

Aryl substituted indoles and the use thereof

Disconnector device

DEUTERATED TIC10

2-(2,4,5-substituted aniline) pyrimidine derivative, pharmaceutical composition and use thereof

DEUTERIUM-SUBSTITUTED OXADIAZOLES

Deuterated organic compound, mixture and composition containing said compound, and organic electronic device